LUCY vs. CLGN, FEMY, DXR, NXL, NMTC, MDAI, PYPD, COCH, BDMD, and POCI
Should you be buying Innovative Eyewear stock or one of its competitors? The main competitors of Innovative Eyewear include CollPlant Biotechnologies (CLGN), Femasys (FEMY), Daxor (DXR), Nexalin Technology (NXL), NeuroOne Medical Technologies (NMTC), Spectral AI (MDAI), PolyPid (PYPD), Envoy Medical (COCH), Baird Medical Investment (BDMD), and Precision Optics (POCI). These companies are all part of the "medical equipment" industry.
Innovative Eyewear vs.
Innovative Eyewear (NASDAQ:LUCY) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.
CollPlant Biotechnologies received 138 more outperform votes than Innovative Eyewear when rated by MarketBeat users. However, 100.00% of users gave Innovative Eyewear an outperform vote while only 59.83% of users gave CollPlant Biotechnologies an outperform vote.
Innovative Eyewear has higher revenue and earnings than CollPlant Biotechnologies. CollPlant Biotechnologies is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.
Innovative Eyewear currently has a consensus target price of $20.00, suggesting a potential upside of 383.09%. CollPlant Biotechnologies has a consensus target price of $12.50, suggesting a potential upside of 303.88%. Given Innovative Eyewear's higher possible upside, equities research analysts plainly believe Innovative Eyewear is more favorable than CollPlant Biotechnologies.
In the previous week, CollPlant Biotechnologies had 1 more articles in the media than Innovative Eyewear. MarketBeat recorded 1 mentions for CollPlant Biotechnologies and 0 mentions for Innovative Eyewear. CollPlant Biotechnologies' average media sentiment score of 1.44 beat Innovative Eyewear's score of 0.96 indicating that CollPlant Biotechnologies is being referred to more favorably in the news media.
1.0% of Innovative Eyewear shares are held by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are held by institutional investors. 6.4% of Innovative Eyewear shares are held by insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Innovative Eyewear has a net margin of -514.01% compared to CollPlant Biotechnologies' net margin of -2,680.00%. CollPlant Biotechnologies' return on equity of -77.05% beat Innovative Eyewear's return on equity.
Innovative Eyewear has a beta of 2.68, suggesting that its share price is 168% more volatile than the S&P 500. Comparatively, CollPlant Biotechnologies has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500.
Summary
CollPlant Biotechnologies beats Innovative Eyewear on 12 of the 19 factors compared between the two stocks.
Get Innovative Eyewear News Delivered to You Automatically
Sign up to receive the latest news and ratings for LUCY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Innovative Eyewear Competitors List
Related Companies and Tools
This page (NASDAQ:LUCY) was last updated on 3/6/2025 by MarketBeat.com Staff
